Fox Chase Cancer Center Welcomes Dr. Dina Ioffe

Dr. Ioffe
Fox Chase Cancer Center is pleased to announce the hiring of Dina Ioffe, MD, as an assistant professor in the Department of Hematology/Oncology.

PHILADELPHIA (September 6, 2023) — Fox Chase Cancer Center is pleased to announce the hiring of Dina Ioffe, MD, as an assistant professor in the Department of Hematology/Oncology.

Ioffe received her bachelor’s degree from Washington University in Saint Louis and her medical degree from the University of Maryland School of Medicine.

She completed her internal medicine residency at the University of Maryland Medical Center, where she also served as an assistant instructor in the Department of Medicine. Ioffe did her hematology/oncology fellowship at Fox Chase and was chief fellow in her senior year.

Ioffe will be seeing patients with gastrointestinal malignancies at both Fox Chase and Temple University Hospital. Her research focuses on the management of patients with hepatocellular carcinoma (HCC).

As a fellow, she was supported by a Fox Chase Cancer Center Young Investigator Award to investigate disparities in patterns of systemic care in patients with HCC using a large real-world database from Flatiron Health. The results were presented at the American Society of Clinical Oncology’s 2023 Gastrointestinal Cancers Symposium.

She is currently leading a multicenter clinical trial examining the effectiveness of multimodal therapy in a diverse patient population with advanced, unresectable HCC, with the ultimate goal of determining the best management of historically underrepresented patients.

In addition, she will also be working on a pilot translational research project exploring biomarkers of aging in vulnerable older patients with metastatic pancreatic cancer.

Ioffe began her tenure at Fox Chase on September 1.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427